Table 1.
Baseline demographics and disease characteristics of Assessment of Spondyloarthritis International Society (ASAS+) patients from the DESIR cohort.
Fig 1.
Serum sclerotin (SOST) level among patients with axial spondyloarthritis (SpA) and controls at baseline.
Each point represents 1 patient. Data are mean ± SD. ***p<0.0001.
Fig 2.
Correlation of SOST serum level with age.
(A) (rs = 0.36; p<0.0001), C-reactive protein (CRP) level (B) (rs = -0.18; p = 0.0001), high-sensitivity CRP (hs-CRP) level (C) (rs = -0.22; p<0.0001), erythrocyte sedimentation rate (ESR) (D) (rs = -0.12, p = 0.007) and Dickkopf-1 (DKK-1) serum levels (E) (rs = 0.15, p = 0.0008); rs: Spearman correlation coefficient.
Table 2.
Correlation between SOST serum level and characteristics of ASAS+ patients of the DESIR cohort.
Fig 3.
(A) Serum DKK-1 level among axial SpA patients and controls at baseline. Each point represents 1 patient. Data are mean ± SD. *** p< 0.0001. (B) Distribution of DKK-1 levels in controls and axial SpA patients.
Fig 4.
Correlation of DKK-1 serum level with systemic inflammation assessed by ESR.
(A) (rs = 0.1, p = 0.03), CRP level (B) (rs = 0.17; p = 0.0001), hs-CRP level (C) (rs = 0.14; p = 0.003), Ankylosing Spondylitis Disease Activity Score (ASDAS)-ESR (D) (rs = 0.11; p = 0.02) and ASDAS-CRP level (E) (rs = 0.13; p = 0.004); rs: Spearman correlation coefficient.
Table 3.
Correlation between DKK-1 serum level and characteristics of ASAS+ patients of the DESIR cohort.